2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Slosman Marvin | CEO | 2,420,866 | Aug 1, 2025 |
| Barry James J | CEO | 2,166,382 | Dec 17, 2019 |
| Holzer Asher | Director | 1,925,110 | Nov 26, 2013 |
| Stuka Paul | Director | 817,910 | Dec 5, 2025 |
| Roubin Gary S | Director | 656,425 | Oct 9, 2025 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 9, 2025 | Feb 23, 2026 | Stuka Paul | Director | Buy | 67.5 | +2,710 | 0.70% | ✗ | $4.9K |
| Jan 15, 2026 | Feb 2, 2026 | Gleason Shane Thomas | Chief Commercial Officer | Sell | 42.5 | -61,194 | -5.10% | ✗ | $99.3K |
| Jan 14, 2026 | Jan 16, 2026 | Ward Scott R. | Director | Neutral | 90.0 | +88,053 | 147.26% | ✗ | - |
| Jan 14, 2026 | Jan 16, 2026 | Tommasoli Andrea | COO | Neutral | 90.0 | +226,695 | 31.15% | ✗ | - |
| Jan 14, 2026 | Jan 16, 2026 | Stuka Paul | Director | Neutral | 90.0 | +132,076 | 15.80% | ✗ | - |
| Jan 14, 2026 | Jan 16, 2026 | Slosman Marvin | CEO | Neutral | 90.0 | +1,114,792 | 46.05% | ✗ | - |
| Jan 14, 2026 | Jan 16, 2026 | ROUBIN GARY S | Director | Neutral | 90.0 | +88,053 | 13.41% | ✗ | - |
| Jan 14, 2026 | Jan 16, 2026 | Lawless Michael A | CFO | Neutral | 90.0 | +226,695 | 48.75% | ✗ | - |
| Jan 14, 2026 | Jan 16, 2026 | Gleason Shane Thomas | Chief Commercial Officer | Neutral | 90.0 | +453,390 | 60.70% | ✗ | - |
| Jan 14, 2026 | Jan 16, 2026 | Dearen Danny L. | Director | Neutral | 90.0 | +44,030 | 75.89% | ✗ | - |
| Jan 14, 2026 | Jan 16, 2026 | COHEN RAYMOND W | Director | Neutral | 90.0 | +44,030 | 91.00% | ✗ | - |
| Jan 14, 2026 | Jan 16, 2026 | BERMAN MICHAEL | Director | Neutral | 90.0 | +88,053 | 17.28% | ✗ | - |
| Dec 30, 2025 | Dec 31, 2025 | Arnold Kathryn | Director | Neutral | 90.0 | +55,556 | 22.44% | ✗ | - |
| Dec 9, 2025 | Dec 11, 2025 | Stuka Paul | Director | Buy | 67.5 | +5,073 | 0.61% | ✗ | $9.2K |
| Dec 5, 2025 | Dec 8, 2025 | Stuka Paul | Director | Buy | 67.5 | +5,073 | 0.61% | ✗ | $9.4K |
| Dec 4, 2025 | Dec 5, 2025 | Stuka Paul | Director | Buy | 78.8 | +10,130 | 1.24% | ✗ | $18.7K |
| Nov 12, 2025 | Nov 13, 2025 | Stuka Paul | Director | Buy | 78.8 | +13,431 | 1.67% | ✗ | $21.8K |
| Oct 7, 2025 | Oct 9, 2025 | ROUBIN GARY S | Director | Neutral | 85.0 | +48,000 | 7.89% | ✗ | - |
| Sep 24, 2025 | Dearen Danny L. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Sep 15, 2025 | Sep 17, 2025 | Kester Thomas J | Director | Neutral | 85.0 | +37,815 | 8.99% | ✗ | - |
| Aug 1, 2025 | COHEN RAYMOND W | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 30, 2025 | Aug 1, 2025 | ROUBIN GARY S | Director | Buy | 90.0 | +41,322 | 7.29% | ✗ | $100K |
| Jul 30, 2025 | Aug 1, 2025 | Kester Thomas J | Director | Buy | 90.0 | +30,991 | 7.95% | ✗ | $75K |
| Jul 30, 2025 | Aug 1, 2025 | Slosman Marvin | CEO | Buy | 61.3 | +10,330 | 0.43% | ✗ | $25K |
| Jul 30, 2025 | Aug 1, 2025 | Stuka Paul | Director | Buy | 83.8 | +20,661 | 2.64% | ✗ | $50K |
| Jun 29, 2025 | Jul 23, 2025 | BERMAN MICHAEL | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 11, 2025 | Jul 23, 2025 | Kester Thomas J | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 1, 2025 | Jul 23, 2025 | Stuka Paul | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 25, 2025 | Jul 23, 2025 | ROUBIN GARY S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 26, 2025 | Lawless Michael A | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 7, 2025 | Jan 10, 2025 | Tommasoli Andrea | COO | Neutral | 90.0 | +232,616 | 46.99% | ✗ | - |
| Jan 7, 2025 | Jan 10, 2025 | Kester Thomas J | Director | Neutral | 85.0 | +32,491 | 9.95% | ✗ | - |
| Jan 7, 2025 | Jan 10, 2025 | Ward Scott R. | Director | Neutral | 90.0 | +16,245 | 37.30% | ✗ | - |
| Jan 7, 2025 | Jan 10, 2025 | ROUBIN GARY S | Director | Neutral | 85.0 | +32,491 | 6.48% | ✗ | - |
| Jan 7, 2025 | Jan 10, 2025 | Slosman Marvin | CEO | Neutral | 90.0 | +558,417 | 30.15% | ✗ | - |
| Jan 7, 2025 | Jan 10, 2025 | Arnold Kathryn | Director | Neutral | 90.0 | +32,491 | 15.11% | ✗ | - |
| Jan 7, 2025 | Jan 10, 2025 | Verta Patrick | EVP Clinical/Medical Affairs | Neutral | 90.0 | +83,072 | 36.36% | ✗ | - |
| Jan 7, 2025 | Jan 10, 2025 | Stuka Paul | Director | Neutral | 85.0 | +48,736 | 7.53% | ✗ | - |
| Jan 7, 2025 | Jan 10, 2025 | Gleason Shane Thomas | Chief Commercial Officer | Neutral | 90.0 | +232,616 | 45.22% | ✗ | - |
| Jan 7, 2025 | Jan 10, 2025 | BERMAN MICHAEL | Director | Neutral | 85.0 | +32,491 | 7.81% | ✗ | - |
| Jan 7, 2025 | Jan 10, 2025 | Shore Craig | CFO | Neutral | 90.0 | +232,616 | 26.44% | ✗ | - |
| Nov 27, 2024 | Ward Scott R. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 24, 2024 | Jun 26, 2024 | BERMAN MICHAEL | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 28, 2024 | Jun 25, 2024 | Kester Thomas J | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 5, 2024 | Jun 7, 2024 | Stuka Paul | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 28, 2024 | May 30, 2024 | ROUBIN GARY S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2024 | Jan 25, 2024 | Kester Thomas J | Director | Neutral | 90.0 | +29,032 | 10.87% | ✗ | - |
| Jan 23, 2024 | Jan 25, 2024 | Verta Patrick | EVP Clinical/Medical Affairs | Neutral | 90.0 | +85,720 | 60.05% | ✗ | - |
| Jan 23, 2024 | Jan 25, 2024 | Gleason Shane Thomas | Chief Commercial Officer | Neutral | 90.0 | +238,625 | 86.54% | ✗ | - |
| Jan 23, 2024 | Jan 25, 2024 | Tommasoli Andrea | COO | Neutral | 90.0 | +238,625 | 93.05% | ✗ | - |
| Jan 23, 2024 | Jan 25, 2024 | Arnold Kathryn | Director | Neutral | 90.0 | +29,032 | 15.61% | ✗ | - |
| Jan 23, 2024 | Jan 25, 2024 | Shore Craig | CFO | Neutral | 90.0 | +238,625 | 37.21% | ✗ | - |
| Jan 23, 2024 | Jan 25, 2024 | ROUBIN GARY S | Director | Neutral | 85.0 | +29,032 | 6.57% | ✗ | - |
| Jan 23, 2024 | Jan 25, 2024 | Slosman Marvin | CEO | Neutral | 90.0 | +563,499 | 43.73% | ✗ | - |
| Jan 23, 2024 | Jan 25, 2024 | Stuka Paul | Director | Neutral | 85.0 | +43,548 | 8.43% | ✗ | - |
| Jan 23, 2024 | Jan 25, 2024 | BERMAN MICHAEL | Director | Neutral | 85.0 | +29,032 | 8.92% | ✗ | - |
| Jan 2, 2024 | Jan 11, 2024 | BERMAN MICHAEL | Director | Neutral | 77.5 | +3,782 | 1.18% | ✗ | - |
| Jan 2, 2024 | Jan 11, 2024 | Arnold Kathryn | Director | Neutral | 67.5 | +1,661 | 0.90% | ✗ | - |
| Jan 2, 2024 | Jan 11, 2024 | Kester Thomas J | Director | Neutral | 77.5 | +3,183 | 1.21% | ✗ | - |
| Jan 2, 2024 | Jan 11, 2024 | ROUBIN GARY S | Director | Neutral | 67.5 | +3,229 | 0.74% | ✗ | - |
| Nov 30, 2023 | Dec 4, 2023 | ROUBIN GARY S | Director | Buy | 95.0 | +50,000 | 12.86% | ✗ | $126.5K |
| Oct 10, 2023 | Verta Patrick | EVP Clinical/Medical Affairs | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 2, 2023 | Oct 4, 2023 | BERMAN MICHAEL | Director | Neutral | 67.5 | +3,106 | 0.97% | ✗ | - |
| Oct 2, 2023 | Oct 4, 2023 | Arnold Kathryn | Director | Neutral | 67.5 | +1,364 | 0.75% | ✗ | - |
| Oct 2, 2023 | Oct 4, 2023 | ROUBIN GARY S | Director | Neutral | 67.5 | +2,652 | 0.69% | ✗ | - |
| Oct 2, 2023 | Oct 4, 2023 | Kester Thomas J | Director | Neutral | 77.5 | +2,614 | 1.00% | ✗ | - |
| Aug 28, 2023 | Aug 30, 2023 | Gleason Shane Thomas | Chief Commercial Officer | Neutral | 85.0 | +19,290 | 7.52% | ✗ | - |
| Jul 1, 2023 | Jul 5, 2023 | ROUBIN GARY S | Director | Neutral | 67.5 | +3,445 | 0.90% | ✗ | - |
| Jul 1, 2023 | Jul 5, 2023 | Kester Thomas J | Director | Neutral | 77.5 | +3,396 | 1.32% | ✗ | - |
| Jul 1, 2023 | Jul 5, 2023 | BERMAN MICHAEL | Director | Neutral | 77.5 | +4,351 | 1.38% | ✗ | - |
| Jul 1, 2023 | Jul 5, 2023 | Arnold Kathryn | Director | Neutral | 67.5 | +1,772 | 0.98% | ✗ | - |
| May 17, 2023 | May 19, 2023 | Slosman Marvin | CEO | Neutral | 90.0 | +1,045,150 | 429.27% | ✗ | - |
| May 17, 2023 | May 19, 2023 | Shore Craig | CFO | Neutral | 90.0 | +522,580 | 440.48% | ✗ | - |
| May 17, 2023 | May 19, 2023 | Stuka Paul | Director | Neutral | 90.0 | +225,680 | 77.59% | ✗ | - |
| May 17, 2023 | May 19, 2023 | Gleason Shane Thomas | VP Global Marketing | Neutral | 90.0 | +256,450 | 100.00% | ✗ | - |
| May 17, 2023 | May 19, 2023 | BERMAN MICHAEL | Director | Neutral | 90.0 | +149,260 | 90.28% | ✗ | - |
| May 17, 2023 | May 19, 2023 | Tommasoli Andrea | COO | Neutral | 90.0 | +179,080 | 231.45% | ✗ | - |
| May 17, 2023 | May 19, 2023 | Kester Thomas J | Director | Neutral | 90.0 | +149,260 | 137.45% | ✗ | - |
| May 17, 2023 | May 19, 2023 | ROUBIN GARY S | Director | Neutral | 90.0 | +149,260 | 63.91% | ✗ | - |
| May 17, 2023 | May 19, 2023 | Arnold Kathryn | Director | Neutral | 90.0 | +149,260 | 467.15% | ✗ | - |
| May 12, 2023 | May 16, 2023 | Stuka Paul | Director | Buy | 97.5 | +175,000 | 151.05% | ✗ | $285.7K |
| May 12, 2023 | May 16, 2023 | Kester Thomas J | Director | Buy | 95.0 | +61,249 | 129.38% | ✗ | $100K |
| May 12, 2023 | May 16, 2023 | BERMAN MICHAEL | Director | Buy | 95.0 | +122,497 | 286.03% | ✗ | $200K |
| May 12, 2023 | May 16, 2023 | ROUBIN GARY S | Director | Buy | 95.0 | +61,249 | 35.55% | ✗ | $100K |
| Apr 1, 2023 | Apr 4, 2023 | BERMAN MICHAEL | Director | Neutral | 90.0 | +9,491 | 28.47% | ✗ | - |
| Apr 1, 2023 | Apr 4, 2023 | Kester Thomas J | Director | Neutral | 90.0 | +7,986 | 20.29% | ✗ | - |
| Apr 1, 2023 | Apr 4, 2023 | Arnold Kathryn | Director | Neutral | 90.0 | +4,167 | 15.00% | ✗ | - |
| Apr 1, 2023 | Apr 4, 2023 | ROUBIN GARY S | Director | Neutral | 82.5 | +8,102 | 4.93% | ✗ | - |
| Mar 20, 2023 | Tommasoli Andrea | COO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 1, 2023 | Gleason Shane Thomas | VP Global Marketing | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 18, 2022 | Aug 22, 2022 | ROUBIN GARY S | Director | Buy | 95.0 | +35,500 | 27.58% | ✗ | $67.8K |
| Nov 10, 2021 | Jan 6, 2022 | Shore Craig | CFO | Neutral | 90.0 | +72,978 | 159.83% | ✗ | - |
| Dec 28, 2021 | Dec 30, 2021 | ROUBIN GARY S | Director | Buy | 95.0 | +16,393 | 14.60% | ✗ | $50.4K |
| Dec 1, 2021 | Dec 2, 2021 | Stuka Paul | Director | Buy | 91.3 | +12,037 | 11.59% | ✗ | $42.3K |
| Nov 29, 2021 | Nov 30, 2021 | Stuka Paul | Director | Buy | 95.0 | +21,549 | 26.19% | ✗ | $76.5K |
| Nov 26, 2021 | Nov 29, 2021 | Stuka Paul | Director | Buy | 77.5 | +1,200 | 1.48% | ✗ | $4.3K |
| Nov 24, 2021 | Nov 26, 2021 | Stuka Paul | Director | Buy | 95.0 | +18,328 | 29.21% | ✗ | $65.1K |
| Nov 22, 2021 | Nov 23, 2021 | Stuka Paul | Director | Buy | 95.0 | +20,392 | 48.15% | ✗ | $72.1K |
| Nov 17, 2021 | Nov 18, 2021 | ROUBIN GARY S | Director | Buy | 95.0 | +25,930 | 30.02% | ✗ | $100K |
| Nov 10, 2021 | Nov 12, 2021 | BERMAN MICHAEL | Director | Neutral | 90.0 | +17,248 | 107.21% | ✗ | - |